Therapy of pulmonary hypertension - The evolution from vasodilators to antiproliferative agents

被引：45

作者：

Rubin, LJ ^{[1
]}

机构：

[1] Univ Calif San Diego, La Jolla, CA 92093 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2002年 / 166卷 / 10期

关键词：

D O I：

10.1164/rccm.2208008

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1308 / 1309

页数：2

共 13 条

[1] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[2] AN IMBALANCE BETWEEN THE EXCRETION OF THROMBOXANE AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION [J].

CHRISTMAN, BW ;

MCPHERSON, CD ;

NEWMAN, JH ;

KING, GA ;

BERNARD, GR ;

GROVES, BM ;

LOYD, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :70-75

[3] Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery [J].

Clapp, LH ;

Finney, P ;

Turcato, S ;

Tran, S ;

Rubin, LJ ;

Tinker, A .

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 26 (02) :194-201

[4] Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension:: With pulmonary arterial hypertension:: A randomized, double-blind, placebo-controlled trial [J].

Galiè, N ;

Humbert, M ;

Vachiéry, JL ;

Vizza, CD ;

Kneussl, M ;

Manes, A ;

Sitbon, O ;

Torbicki, A ;

Delcroix, M ;

Naeije, R ;

Hoeper, M ;

Chaouat, A ;

Morand, S ;

Besse, B ;

Simonneau, G .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (09) :1496-1502

[5] EXPRESSION OF ENDOTHELIN-1 IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].

GIAID, A ;

YANAGISAWA, M ;

LANGLEBEN, D ;

MICHEL, RP ;

LEVY, R ;

SHENNIB, H ;

KIMURA, S ;

MASAKI, T ;

DUGUID, WP ;

STEWART, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24) :1732-1739

[6] New treatments for pulmonary arterial hypertension [J].

Hoeper, MM ;

Galiè, N ;

Simonneau, G ;

Rubin, LJ .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (09) :1209-1216

[7] Isoprenoids as mediators of the biological effects of statins [J].

Liao, JK .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (03) :285-288

[8] Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats [J].

Nishimura, T ;

Faul, JL ;

Berry, GJ ;

Vaszar, LT ;

Qiu, DM ;

Pearl, RG ;

Kao, PN .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (10) :1403-1408

[9] Inhaled iloprost for severe pulmonary hypertension [J].

Olschewski, H ;

Simonneau, G ;

Galiè, N ;

Higenbottam, T ;

Naeije, R ;

Rubin, LJ ;

Nikkho, S ;

Speich, R ;

Hoeper, MM ;

Behr, J ;

Winkler, J ;

Sitbon, O ;

Popov, W ;

Ghofrani, HA ;

Manes, A ;

Kiely, DG ;

Ewert, R ;

Siedentop, H ;

Seeger, W .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (05) :322-329

[10] Bosentan therapy for pulmonary arterial hypertension [J].

Rubin, LJ ;

Badesch, DB ;

Barst, RJ ;

Galiè, N ;

Black, CM ;

Keogh, A ;

Pulido, T ;

Frost, A ;

Roux, S ;

Leconte, I ;

Landzberg, M ;

Simonneau, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :896-903

← 1 2 →